Announcements Trials

Browse Landscape

Phase

Phase 3 3 Phase 2 1

Status

Sponsor Class

OTHER 33 NIH 6 NETWORK 6 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 272 Paclitaxel 267 Gemcitabine 244 Bevacizumab 225 Cisplatin 216 pembrolizumab 213 Docetaxel 210 Pemetrexed 162 Capecitabine 148 Fluorouracil 129 Oxaliplatin 121 Cyclophosphamide 121 Nivolumab 112 Dexamethasone 99 Trastuzumab 89 Leucovorin 87 Cetuximab 85 Rituximab 83 Irinotecan 82 Injections 80 Erlotinib Hydrochloride 70 Prednisone 68 Doxorubicin 68 Temozolomide 67 atezolizumab 65 Ipilimumab 64 Bortezomib 64 Fulvestrant 59 Radiotherapy 54 Drug Therapy 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Observation × Clear all

NCT03770299 2022-03-24

CheckMate 9TN

Bristol-Myers Squibb

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡